Top1000 Scholar

Scholarly Index

Neha J. Pagidipati

Alnylam Pharmaceuticals (United States); 7,689 total citations; 231 total publications; best world rank #152

Alnylam Pharmaceuticals (United States)

7,689Total citations
231Total publications
39H-index

Published ranking records

FieldWindowWorld rankNational rankImpact score
Diabetes, Cardiovascular Risks, and Lipoproteins2021-2025152US 4695.55
Diabetes Treatment and Management2021-2025339US 11896.30
Lipoproteins and Cardiovascular Health2021-2025265US 9194.75
Metabolism, Diabetes, and Cancer2021-2025806US 19881.41
Medication Adherence and Compliance2021-2025581US 19776.66
Pharmacology and Obesity Treatment2021-2025988US 35757.85